Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
CALL
Molina Healthcare
MOH
$11.1B
| $329K | ﹤0.01% |
1,800
| – | – |
|
3477
Collegium Pharmaceutical
COLL
$916M
| $328K | ﹤0.01% |
15,795
-3,137
| -17% | -$56.6K |
|
3478
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $328K | ﹤0.01% |
4,060
| – | – |
|
3479
Quanterix
QTRX
$122M
| $327K | ﹤0.01% |
9,686
-4,431
| -31% | -$143K |
|
3480
CALL
Encompass Health
EHC
$12.2B
| $325K | ﹤0.01% |
6,285
| – | – |
|
3481
Live Oak Bancshares
LOB
$2B
| $325K | ﹤0.01% |
12,846
-2,594
| -17% | -$50.5K |
|
3482
PUT
Southern Company
SO
$107B
| $325K | ﹤0.01% |
6,000
-4,700
| -44% | -$251K |
|
3483
Ashland
ASH
$3.38B
| $324K | ﹤0.01% |
4,573
+474
| +12% | +$35.1K |
|
3484
Global Water Resources
GWRS
$247M
| $324K | ﹤0.01% |
30,038
-1,168
| -4% | -$12.8K |
|
3485
Lindblad Expeditions
LIND
$2.2B
| $324K | ﹤0.01% |
37,984
+12,277
| +48% | +$104K |
|
|
EGIO
3486
DELISTED
Edgio, Inc. Common Stock
EGIO
| $324K | ﹤0.01% |
1,402
-195
| -12% | -$48.8K |
|
|
CCF
3487
DELISTED
Chase Corporation
CCF
| $324K | ﹤0.01% |
3,396
-656
| -16% | -$66.7K |
|
3488
Tronox
TROX
$952M
| $323K | ﹤0.01% |
40,985
-8,806
| -18% | -$73.5K |
|
|
FAZ
3489
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$84.6M
| $322K | ﹤0.01% |
266
-15
| -5% | -$18.2K |
|
3490
Green Brick Partners
GRBK
$3.03B
| $322K | ﹤0.01% |
19,929
-8,879
| -31% | -$131K |
|
|
XLRN
3491
DELISTED
Acceleron Pharma
XLRN
| $322K | ﹤0.01% |
2,869
-10,271
| -78% | -$1.02M |
|
|
PRVL
3492
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $322K | ﹤0.01% |
31,625
+14,493
| +85% | +$194K |
|
3493
CALL
Weibo
WB
$1.88B
| $321K | ﹤0.01% |
8,800
| – | – |
|
|
MILN
3494
Global X Millennial Consumer ETF
MILN
$103M
| $320K | ﹤0.01% |
10,250
| – | – |
|
3495
Columbia Sportswear
COLM
$2.94B
| $319K | ﹤0.01% |
3,668
-25,395
| -87% | -$2.11M |
|
3496
Stock Yards Bancorp
SYBT
$2.64B
| $319K | ﹤0.01% |
9,360
-1,954
| -17% | -$78K |
|
3497
CALL
Toronto Dominion Bank
TD
$205B
| $319K | ﹤0.01% |
6,900
-3,900
| -36% | -$182K |
|
3498
FS Bancorp
FSBW
$323M
| $318K | ﹤0.01% |
15,504
-80
| -0.5% | -$1.56K |
|
3499
PUT
Ionis Pharmaceuticals
IONS
$9.51B
| $318K | ﹤0.01% |
6,700
-3,700
| -36% | -$206K |
|
3500
Gogo Inc
GOGO
$383M
| $316K | ﹤0.01% |
34,168
-734
| -2% | -$4.01K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.